WEBINAR | Adapt or Fall Behind: Mastering the Inflation Reduction Act’s Impact on Biopharmaceutical Market Access
With the Inflation Reduction Act (IRA) now set as a cornerstone of modern healthcare legislation, adapting to its mandates is not just advisable but essential. This webinar focuses on equipping commercial and market access professionals with the knowledge and strategies needed to effectively adjust to the IRA's provisions.
Don’t miss this opportunity to understand the enduring nature of these changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access, ensuring your organization not only complies but excels.
Adapt or Fall Behind: Mastering the Inflation Reduction Act’s Impact on Biopharmaceutical Market Access
In this webinar, attendees will:
LEARN the new compliance requirements and regulatory adjustments under the Inflation Reduction Act.
EXPLORE the implications of the IRA on drug development, pricing and market access, and how to mitigate risk and capitalize on new opportunities.
DISCOVER strategic planning techniques to continue driving innovation while maintaining compliance with the new regulatory framework.
DOWNLOAD THE WEBINAR PRESENTATION SLIDES HERE.
Speakers
Tiffany McCaslin
Managing Director, Value & Access Consulting, Syneos Health
Peter Zou, PhD
Director, Value & Access Consulting, Syneos Health
Related Content
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Capabilities
Insights
Syneos Health Podcast | Real Talk About the Inflation Reduction Act
PRESENTATION: Inflation Reduction Act Data Collection Provisions
